Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06421766 · ClinicalTrials.gov registry record
Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures
A clinical trial, sponsored by Oticon Medical.
- Completed
- Registry status
- 234
- Enrollment target
NCT06421766: Completed study, sponsored by Oticon Medical.
NCT06421766 is a clinical trial that has completed, run by Oticon Medical. The registered enrollment target is 234 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06421766 has completed, sponsored by Oticon Medical.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
This retrospective study is conducted to gain more knowledge on use and complications of 3mm long implants used in percutaneous (through the skin) bone-anchored hearing system (BAHS) surgeries in adults. Patients included have already been treated and recieved an implant with the wide diameter (Ø: 4.5 mm) design, either of 3- or 4mm length. The main purpose of the study is to investigate implant survival three months after implantation.
Primary Outcome
Implant in place in skull bone at 3 months (Yes/No).
Interventions
- DEVICE BAHS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2024-09-25 |
What the finished NCT06421766 record still lists
NCT06421766 is an observational study that tracks outcomes without assigning an intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which BAHS is the first listed.
NCT06421766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06421766 about?
NCT06421766 is a clinical study titled "Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures". This retrospective study is conducted to gain more knowledge on use and complications of 3mm long implants used in percutaneous (through the skin) bone-anchored hearing system (BAHS) surgeries in adults. Patients included have already been treated and recieved an implant with the wide diameter (Ø: 4...
What is the current status of trial NCT06421766?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2024-03-08. Estimated completion is 2024-09-25.
What interventions are being tested in trial NCT06421766?
The interventions under investigation include: BAHS (DEVICE).
Who is sponsoring clinical trial NCT06421766?
This trial is sponsored by Oticon Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI